The company plans to launch the device in Europe late next week, providing competition for AtriCure’s AtriClip product.

A Minnesota judge dismissed a class action lawsuit alleging securities fraud related to insulin pumps made by Medtronic (NYSE ...

Medtronic PLC investors again failed to adequately allege the device maker’s statements about its MiniMed insulin pumps ...

Medtronic (NYSE: MDT) announced today that it received CE mark approval for its Penditure LAA exclusion system.

ViCentra's Kaleido is "the smallest, thinnest, lightest, most precise insulin patch pump in its class," CEO Tom Arnold said ...

Medtronic plc (NYSE:MDT) has been rewarding shareholders with growing dividends for the past 48 years, which makes it one of ...

Medtronic (MDT) closed at $94.30 in the latest trading session, marking a -1.5% move from the prior day. This change lagged the S&P 500's daily loss of 0.5%. Elsewhere, the Dow lost 0.38%, while the ...

Dallara, president of Medtronic’s diabetes business, discussed the segment’s turnaround and why she sees a benefit in ...

Medtronic plc MDT recently received Food and Drug Administration (“FDA”) approval for the minimally invasive implantable tibial neuromodulation (ITNM) Altaviva device. The therapy is inserted near the ...

Medtronic (NYSE:MDT) announced that its Instinct sensor, made by Abbott, is now available to order with the MiniMed 780G pump ...

The Smart Medical Devices Market Size valued at US$ 61.7 billion in 2024, is projected to reach US$ 180.4 billion by 2033, ...

MDT delivered solid fiscal Q1 2026 results, with 8.4% revenue growth and standout performance in Cardiac Ablation and Diabetes segments. Read the latest analysis on the stock here.